Symptomatic use of carbidopa in autonomic disorders
This study retrospectively characterized patients in our autonomic clinic who were prescribed carbidopa for open label treatment of autonomic symptoms. 23 patients were included; approximately half had postural orthostatic tachycardia syndrome. Those with documented plasma catecholamines had elevated standing norepinephrine. Patients typically had multiple comorbidities and multiple failed therapies.
Source: Autonomic Neuroscience: Basic and Clinical - Category: Neuroscience Authors: Elisabeth P. Golden, Christine J. Park, Steven Vernino Tags: Short Communication Source Type: research